Additionally, the woman – BRCA1 carrier who chooses to undergo bilateral salpingoophorectomy more closely to the age of 40, may face an increased risk of ovarian cancer which is estimated to be 4%. The gene discussed is BRCA1; the disease is ovarian cancer.